Regulora is a PDT that is accessed through a smartphone app. It consists of seven therapy sessions provided over three months, with practice sessions between. Regulora is delivers Gut-Directed Hypnotherapy (GDH) and includes the collection of adherence data and patient reported outcomes using clinically-validated survey instruments. Unlike most digital therapeutics that focus on behavioral health issues, Regulora treats abdominal pain, a somatic symptom that is the chief IBS complaint. For decades, in-person psychological interventions have been effective in treating IBS but were accessible to very few patients.

Regulora provides broad access to this treatment through a mechanism familiar to both patients and doctors: obtaining a prescription. By providing physicians an easy way to prescribe treatment and patients a convenient way to undergo therapy privately at home, Regulora offers a non-drug option that addresses the stigma often associated with bowel problems and psychological interventions.

metaMe Health is a pioneer in developing Prescription Digital Therapeutics (PDTs). In 2022, our work was recognized by being included on the “50 on Fire” list of up-and-coming Chicago companies, being named one of the Top 150 most promising Digital Health Companies of 2022 nationwide by CBInsights, and being selected as a finalist in the LyfeBulb-Bristol Myers Squibb Inflammatory Bowel Disease Challenge. In 2021, our lead product Regulora® became the first FDA-cleared PDT specifically for abdominal pain associated with irritable bowel syndrome (IBS) in adults. More than 30 million Americans are affected by IBS, and the abdominal pain, diarrhea, and/or constipation that comes with it. Regulora provides relief by digitizing a standardized Brain-Gut therapy approach that has been clinically proven to be effective in reducing IBS symptoms.

Our AI-powered Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) platform is transforming how healthcare providers manage chronic conditions and monitor patients remotely. By leveraging AI, our solution empowers medical practices, clinics, and healthcare organizations to deliver proactive, data-driven care while maximizing efficiency and enhancing patient engagement.

Our AI-powered Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) platform is transforming how healthcare providers manage chronic conditions and monitor patients remotely. By leveraging AI, our solution empowers medical practices, clinics, and healthcare organizations to deliver proactive, data-driven care while maximizing efficiency and enhancing patient engagement.

Non-drug therapy with no side effects

mobriseHealth is purpose-built for continuous patient monitoring, remote engagement, and chronic care management. It enables real-time data collection, actionable insights, and patient interactions outside of traditional clinical settings.

EHRs are primarily designed to store patient data and facilitate documentation during in-person visits. 

As compared to our competitors, mobriseHealth provides easy to use, fully integrated RPM and CCM capabilities, allowing providers to track real-time health data and proactively manage chronic conditions with coordinated care plans in one unified solution.